A Phase II Proof of Concept study of DCP-001 in Acute Myeloid Leukemia.
Phase of Trial: Phase II
Latest Information Update: 24 Oct 2017
At a glance
- Drugs DCP 001 (Primary)
- Indications Acute myeloid leukaemia
- Focus Proof of concept; Therapeutic Use
- 24 Oct 2017 New trial record